InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
1.140
-0.070 (-5.79%)
At close: Apr 28, 2026, 4:00 PM EDT
1.190
+0.050 (4.39%)
After-hours: Apr 28, 2026, 4:22 PM EDT
InspireMD Revenue
In the year 2025, InspireMD had annual revenue of $8.98M with 28.11% growth. InspireMD had revenue of $3.15M in the quarter ending December 31, 2025, with 61.57% growth.
Revenue (ttm)
$8.98M
Revenue Growth
+28.11%
P/S Ratio
6.11
Revenue / Employee
$70,701
Employees
127
Market Cap
54.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.98M | 1.97M | 28.11% |
| Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
| Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
| Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
| Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Pulmonx | 90.50M |
| LENSAR | 58.44M |
| electroCore | 32.03M |
| Sensus Healthcare | 27.48M |
| Baird Medical Investment Holdings | 22.54M |
| Spectral AI | 19.65M |
| Picard Medical | 4.94M |
NSPR News
- 1 day ago - InspireMD to Announce First Quarter 2026 Financial Results - GlobeNewsWire
- 14 days ago - InspireMD Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 4 weeks ago - InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - InspireMD Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - GlobeNewsWire